Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

被引：24
|
作者：
Bourhis, J
Etessami, A
Wilbault, P
Lusinchi, A
Calais, G
Lapeyre, M
Pignon, JP
机构：
[1] Inst Gustave Roussy, Dept Radiat Oncol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Stat, F-94805 Villejuif, France
[3] CHU Tours, Clin Oncol & Radiotherapie, Tours, France
[4] Ctr Alexis Vautrin, Nancy, France
来源：
CURRENT OPINION IN ONCOLOGY | 2004年 / 16卷 / 03期
关键词：
head and neck squamous cell carcinoma; hyperfractionation; accelerated radiotherapy; acute and late effects;
D O I：
10.1097/00001622-200405000-00004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of review This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma. Recent findings Both hyperfractionated RT and accelerated RT may improve tumor control probability as compared to conventional RT, along with increased but manageable toxicity and a modest improvement in survival. Summary Altered RT is a tool that can improve the results obtained with conventional RT in Head and squamous cell carcinoma.
引用
收藏
页码：215 / 219
页数：5
相关论文
共 50 条
  • [21] Radiotherapy for Cutaneous Squamous and Basal Cell Carcinomas of the Head and Neck
    Mendenhall, William M.
    Amdur, Robert J.
    Hinerman, Russell W.
    Cognetta, Armand B.
    Mendenhall, Nancy P.
    LARYNGOSCOPE, 2009, 119 (10): : 1994 - 1999
  • [22] Neutron radiotherapy for adenoid cyst carcinomas of the head and neck region
    Sauerwein, W
    Adamczyk, M
    Arweiler-Harbeck, D
    Hideghéty, K
    Jahnke, K
    Stuschke, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 35 - 35
  • [23] Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy
    Tonneau, M.
    Nebbache, R.
    Larnaudie, A.
    Thureau, S.
    Pointreau, Y.
    Blanchard, P.
    Thariat, J.
    CANCER RADIOTHERAPIE, 2024, 28 (01): : 83 - 92
  • [24] Altered fractionation in the management of head and neck cancer
    Ang, KK
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1998, 73 (04) : 395 - 399
  • [25] Clinical trial design limitations in head and neck squamous cell carcinomas
    Yun, Hwan Jung
    Bogaerts, Jan
    Awada, Ahmad
    Lacombe, Denis
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (03) : 210 - 215
  • [26] Altered fractionation radiotherapy in head and neck squamous cell carcinoma
    Mallick, Supriya
    Benson, Rony
    Julka, Pramod K.
    Rath, Goura K.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (02) : 73 - 80
  • [27] Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis
    Bourhis, J
    Audry, H
    Overgaard, J
    Ang, K
    Dische, S
    Horiot, J
    Hliniak, A
    O'Sullivan, B
    Dobrowsky, W
    Skladowski, K
    Fallai, C
    Hay, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S190 - S191
  • [28] Current trends in surgical management of head and neck carcinomas
    Bauer, AM
    NURSING CLINICS OF NORTH AMERICA, 2001, 36 (03) : 501 - +
  • [29] Management of metastatic head and neck squamous cell carcinomas
    Saada, E.
    Ferrand, F. -R.
    Peyrade, F.
    Guigay, J.
    ONCOLOGIE, 2015, 17 (5-6) : 245 - 249
  • [30] Serum and saliva cytokines in mice after fractionated radiotherapy of the head and neck region
    Zlygosteva, O.
    Juvkam, I. Solgard
    Aass, H. C.
    Galtung, H.
    Soland, T.
    Malinen, E.
    Edin, N. Frederike Jeppesen
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S691 - S691
12345